Last Price
0.024
Today's Change
-0.001 (4.00%)
Day's Change
0.024 - 0.025
Trading Volume
5,461,935
Overview
Market Cap
65 Million
Shares Outstanding
2 Billion
Avg Volume
16,608,652
Avg Price (50 Days)
0.05
Avg Price (200 Days)
0.04
PE Ratio
-2.40
EPS
-0.01
Earnings Announcement
20-Feb-2025
Previous Close
0.03
Open
0.03
Day's Range
0.024 - 0.025
Year Range
0.015 - 0.099
Trading Volume
5,461,935
Price Change Highlight
1 Day Change
-4.00%
5 Day Change
-14.29%
1 Month Change
-42.86%
3 Month Change
-61.29%
6 Month Change
-23.96%
Ytd Change
15.87%
1 Year Change
21.67%
3 Year Change
-78.89%
5 Year Change
166.67%
10 Year Change
-42.56%
Max Change
-96.35%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, Alzheimer's disease, depression with cognitive impairment, and anxiety, sleep, and behavioral problems in fragile X syndrome. The company was formerly known as Actinogen Limited and changed its name to Actinogen Medical Limited in November 2015. Actinogen Medical Limited was incorporated in 1999 and is based in Sydney, Australia.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Apps
Top Articles
1
2
CEO Morning Brief
RBA Set to Extend Rate Pause as Housing Crisis Props Up Prices
3
CEO Morning Brief
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
